Valuation: Olympus Corporation

Market Cap 2,265B 14.32B 12.26B 11.41B 10.53B 19.77B 1,371B 20.1B 134B 52.78B 688B 53.81B 52.63B P/E 2027 *
22.1x
P/E 2028 * 18.8x
Enterprise Value 2,347B 14.83B 12.71B 11.82B 10.91B 20.48B 1,421B 20.82B 139B 54.69B 713B 55.75B 54.53B EV / Sales 2027 *
2.18x
EV / Sales 2028 * 2.1x
Free-Float
94.58%
Yield 2027 *
1.45%
Yield 2028 * 1.51%
1 day+3.03%
1 week+1.87%
Current month+19.51%
1 month+24.31%
3 months+19.30%
6 months+38.35%
Current year+7.34%
1 week 12.91
Extreme 12.91
13.64
1 month 10.38
Extreme 10.38
13.64
Current year 8.08
Extreme 8.08
13.64
1 year 8.08
Extreme 8.08
13.73
3 years 8.08
Extreme 8.08
19.69
5 years 8.08
Extreme 8.08
74.99
10 years 6.26
Extreme 6.2625
74.99
Manager TitleAgeSince
Chief Executive Officer 63 01/06/2025
Director of Finance/CFO 59 01/04/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 69 01/04/2023
Director/Board Member 41 01/06/2019
Director/Board Member 63 01/06/2019
Change 5-day change 1-year change 3-year change Capi.($)
+3.03%+1.87% - - 14.09B
+4.16%+1.41%+25.84%+15.24% 218B
+5.97%+1.96%+1.19%-15.87% 140B
+1.67%-0.87%-17.36%+39.09% 138B
+3.05%+1.60%-49.53%+3.63% 73.14B
+1.43%-1.47%+17.85%+20.50% 52.44B
+1.32%+0.99%-15.35%-12.15% 50.85B
+4.70%+3.96%+31.54%+30.32% 41.92B
+3.64%+0.20%+43.69%+54.01% 39.42B
+2.74%+2.57%+1.98%+9.16% 32.81B
Average +2.81%-1.97%+4.43%+15.99% 87.43B
Weighted average by Cap. +3.15%-2.40%+3.86%+13.88%

Financials

2027 *2028 *
Net sales 1,078B 6.81B 5.83B 5.43B 5.01B 9.4B 652B 9.56B 63.76B 25.11B 327B 25.6B 25.04B 1,115B 7.05B 6.04B 5.62B 5.18B 9.73B 675B 9.9B 65.99B 25.99B 339B 26.49B 25.91B
Net income 102B 644M 551M 513M 473M 889M 61.66B 904M 6.03B 2.37B 30.95B 2.42B 2.37B 121B 765M 655M 610M 562M 1.06B 73.28B 1.07B 7.16B 2.82B 36.78B 2.88B 2.81B
Net Debt 81.71B 516M 442M 412M 380M 713M 49.47B 725M 4.83B 1.9B 24.83B 1.94B 1.9B 77.99B 493M 422M 393M 362M 681M 47.21B 692M 4.61B 1.82B 23.7B 1.85B 1.81B
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
19/08/26 $13.60 +3.03% 35,908
18/08/26 $13.20 +1.93% 75,314
17/08/26 $12.95 -1.52% 18,903
14/08/26 $13.15 +1.54% 26,117
13/08/26 $12.95 -0.99% 59,857
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,131.50JPY
Average target price
2,034.62JPY
Spread / Average Target
-4.55%

Quarterly revenue - Rate of surprise